A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)
Pan, Elizabeth, Xie, Wanling, Ajmera, Archana, Araneta, Arlene, Jamieson, Christina, Folefac, Edmund, Hussain, Arif, Kyriakopoulos, Christos E, Olson, Adam, Parikh, Mamta, Parikh, Rahul, Saraiya, Biren, Ivy, S Percy, Van Allen, Eliezer M, Lindeman, Neal I, Kochupurakkal, Bose S, Shapiro, Geoffrey I, McKay, Rana R
Published in Molecular cancer therapeutics (03.04.2023)
Published in Molecular cancer therapeutics (03.04.2023)
Get full text
Journal Article
A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
McKay, Rana R., Liu, Lin, Pu, Minya, Araneta, Arlene, Wang, Luke, Castano, Neremiah, Gomez, Jennifer, Ajmera, Archana, Ye, Huihui, Pili, Roberto, Runcie, Karie, McHugh, Deaglan Joseph, Offit, Kenneth, Paller, Channing Judith, Haas, Naomi B., Javier-Desloges, Juan, Kane, Christopher J., Seibert, Tyler M, Bagrodia, Aditya
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
A phase 1/2 study of combination olaparib and radium-223 in men with metastatic castration-resistant prostate cancer with bone metastases (COMRADE): A trial in progress
Jani, Chinmay, Xie, Wanling, Ajmera, Archana, Araneta, Arlene, Jamieson, Christina, Folefac, Edmund, Hussain, Arif, Kyriakopoulos, Christos, Olson, Adam C., Parikh, Mamta, Parikh, Rahul Atul, Saraiya, Biren, Jabbour, Salma K., Ivy, S. Percy, Van Allen, Eliezer Mendel, Lindeman, Neal Ian, Kochupurakkal, Bose, Shapiro, Geoffrey, McKay, Rana R.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article